These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15951590)

  • 1. Obesity hypertension: the rationale for renin-angiotensin system blockade.
    Chan NN; Tong PC; Kong AP; Chan JC
    Hong Kong Med J; 2005 Jun; 11(3):217-20. PubMed ID: 15951590
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-inflammatory action of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and the prevention of diabetes mellitus in obese patients with hypertension.
    Mascitelli L; Pezzetta F
    Hong Kong Med J; 2005 Oct; 11(5):424. PubMed ID: 16219969
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms.
    van der Zijl NJ; Moors CC; Goossens GH; Blaak EE; Diamant M
    Diabetes Obes Metab; 2012 Jul; 14(7):586-95. PubMed ID: 22226145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a rationale for angiotensin blockade in the management of obesity hypertension?
    Sharma AM
    Hypertension; 2004 Jul; 44(1):12-9. PubMed ID: 15173127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New treatment strategies for patients with hypertension and insulin resistance.
    Kurtz TW
    Am J Med; 2006 May; 119(5 Suppl 1):S24-30. PubMed ID: 16563944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 8. Obesity, essential hypertension and renin-angiotensin system.
    Segura J; Ruilope LM
    Public Health Nutr; 2007 Oct; 10(10A):1151-5. PubMed ID: 17903324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
    Middeke M
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antihypertensive agents on the development of type 2 diabetes mellitus.
    Stump CS; Hamilton MT; Sowers JR
    Mayo Clin Proc; 2006 Jun; 81(6):796-806. PubMed ID: 16770980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual blockade of renin-angiotensin system. Data do not support claimed benefit of combination over single treatment.
    McCormack J; Levine M
    BMJ; 2001 May; 322(7295):1183. PubMed ID: 11379586
    [No Abstract]   [Full Text] [Related]  

  • 13. Renin-angiotensin system blockade: to what extent?
    Ménard J; Azizi M
    J Hypertens; 2004 Mar; 22(3):459-62. PubMed ID: 15076148
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system.
    Cooper ME; Tikellis C; Thomas MC
    J Hypertens Suppl; 2006 Mar; 24(1):S57-63. PubMed ID: 16601575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of angiotensin receptor blockers in diabetic nephropathy.
    Sharma AM; Weir MR
    Postgrad Med; 2011 May; 123(3):109-21. PubMed ID: 21566421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of arterial hypertension in obese patients.
    Wenzel UO; Benndorf R; Lange S
    Semin Nephrol; 2013 Jan; 33(1):66-74. PubMed ID: 23374895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of renin-angiotensin system blockades in reciprocal relationship between insulin resistance and endothelial dysfunction.
    Koh KK; Sakuma I; Quon MJ
    Hypertension; 2010 Dec; 56(6):e169; author reply e170. PubMed ID: 21059993
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-diabetic effect of blockade of the renin-angiotensin system.
    Ando K; Fujita T
    Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
    Minami J; Ishimitsu T; Matsuoka H
    Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of hypertension in patients with type 2 diabetes mellitus].
    Hess K
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2489-92. PubMed ID: 23114910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.